Atlas Trials

Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine

Clinical trial NCT04881396 · COMPLETED

Trial details

NCT number
NCT04881396
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19 VaccinesHemodialysis Complication
Start date
2021-05-10
Primary completion
2022-02-15
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.